WesBanco Bank’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-3,639
| Closed | -$201K | – | 698 |
|
|
2026
Q1 | $201K | Buy |
+3,639
| New | +$197K | 0.01% | 649 |
|
|
2022
Q3 | – | Sell |
-6,676
| Closed | -$363K | – | 437 |
|
|
2022
Q2 | $363K | Buy |
6,676
+40
| +0.6% | +$2.21K | 0.02% | 444 |
|
|
2022
Q1 | $361K | Hold |
6,636
| – | – | 0.01% | 460 |
|
|
2021
Q4 | $366K | Sell |
6,636
-1,260
| -16% | -$65.5K | 0.01% | 469 |
|
|
2021
Q3 | $377K | Buy |
7,896
+461
| +6% | +$23.2K | 0.01% | 457 |
|
|
2021
Q2 | $370K | Buy |
7,435
+880
| +13% | +$42.3K | 0.01% | 461 |
|
|
2021
Q1 | $293K | Buy |
+6,555
| New | +$298K | 0.01% | 486 |
|
|
2020
Q3 | $327K | Buy |
6,963
+120
| +2% | +$6.01K | 0.02% | 409 |
|
|
2020
Q2 | $349K | Sell |
6,843
-3,315
| -33% | -$170K | 0.02% | 395 |
|
|
2020
Q1 | $481K | Sell |
10,158
-724
| -7% | -$38.6K | 0.03% | 334 |
|
|
2019
Q4 | $639K | Sell |
10,882
-1,227
| -10% | -$68.3K | 0.03% | 339 |
|
|
2019
Q3 | $646K | Hold |
12,109
| – | – | 0.03% | 330 |
|
|
2019
Q2 | $606K | Sell |
12,109
-484
| -4% | -$24.3K | 0.03% | 334 |
|
|
2019
Q1 | $658K | Buy |
12,593
+3,290
| +35% | +$164K | 0.03% | 321 |
|
|
2018
Q4 | $444K | Sell |
9,303
-409
| -4% | -$20.1K | 0.03% | 341 |
|
|
2018
Q3 | $488K | Hold |
9,712
| – | – | 0.02% | 368 |
|
|
2018
Q2 | $489K | Sell |
9,712
-700
| -7% | -$35.3K | 0.03% | 361 |
|
|
2018
Q1 | $508K | Buy |
10,412
+400
| +4% | +$18.6K | 0.03% | 359 |
|
|
2017
Q4 | $444K | Sell |
10,012
-200
| -2% | -$9.24K | 0.03% | 279 |
|
|
2017
Q3 | $518K | Hold |
10,212
| – | – | 0.03% | 344 |
|
|
2017
Q2 | $551K | Hold |
10,212
| – | – | 0.03% | 330 |
|
|
2017
Q1 | $538K | Buy |
10,212
+280
| +3% | +$14.2K | 0.03% | 312 |
|
|
2016
Q4 | $478K | Sell |
9,932
-568
| -5% | -$28.1K | 0.03% | 330 |
|
|
2016
Q3 | $566K | Buy |
10,500
+640
| +6% | +$35.1K | 0.03% | 308 |
|
|
2016
Q2 | $534K | Sell |
9,860
-80
| -0.8% | -$4.21K | 0.03% | 311 |
|
|
2016
Q1 | $504K | Sell |
9,940
-367
| -4% | -$18.3K | 0.03% | 308 |
|
|
2015
Q4 | $520K | Sell |
10,307
-4,682
| -31% | -$239K | 0.03% | 301 |
|
|
2015
Q3 | $720K | Sell |
14,989
-3,304
| -18% | -$172K | 0.04% | 273 |
|
|
2015
Q2 | $953K | Buy |
18,293
+2,816
| +18% | +$159K | 0.05% | 248 |
|
|
2015
Q1 | $892K | Buy |
15,477
+400
| +3% | +$22.9K | 0.05% | 253 |
|
|
2014
Q4 | $805K | Buy |
15,077
+634
| +4% | +$35.5K | 0.04% | 271 |
|
|
2014
Q3 | $830K | Sell |
14,443
-2,496
| -15% | -$153K | 0.05% | 262 |
|
|
2014
Q2 | $1.13M | Sell |
16,939
-2,376
| -12% | -$161K | 0.06% | 224 |
|
|
2014
Q1 | $1.29M | Sell |
19,315
-2,478
| -11% | -$168K | 0.07% | 203 |
|
|
2013
Q4 | $1.46M | Buy |
21,793
+872
| +4% | +$56.5K | 0.08% | 187 |
|
|
2013
Q3 | $1.31M | Buy |
20,921
+320
| +2% | +$20.6K | 0.08% | 189 |
|
|
2013
Q2 | $1.29M | Buy |
+20,601
| New | +$1.31M | 0.08% | 177 |
|
Other funds holding GSK
JEST
WesBanco Bank's GSK Position: Q2 2026 in Review
WesBanco Bank sold out of GSK (GSK) in Q2 2026, closing a stake of 3,639 shares — an estimated $201K sold.
WesBanco Bank first reported a position in GSK in Q2 2013 and held it in 37 quarters. The position peaked at $1.46M in Q4 2013. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.
- WesBanco Bank reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
- WesBanco Bank sold 3,639 GSK shares in Q2 2026, an estimated $201K.
- WesBanco Bank first reported a position in GSK in Q2 2013 and held it in 37 quarters.
- WesBanco Bank's GSK position peaked at $1.46M in Q4 2013.
- 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.
Based on WesBanco Bank's 13F filing for Q2 2026, filed 28 Jul 2026.